The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety
- PMID: 15462575
- DOI: 10.3928/0090-4481-20040901-11
The role of the Vaccine Adverse Event Reporting system (VAERS) in monitoring vaccine safety
Abstract
The role of the health professional in supporting the national passive surveillance system is essential, as the first hint of a potential problem usually originates with the astute clinician who reports a case to the appropriate source. The investigation that resulted in the voluntary withdrawal of rotavirus vaccine was triggered by nine reports to VAERS of intussuception, eight of which had occurred within 1 week of the first dose of this vaccine. Health professionals have access to the most complete information related to adverse events experienced by their patients. Any index of suspicion that a serious event or death may be related to vaccination is reason for the health professional to submit a VAERS report. Determination of whether an event was caused by the vaccine is not a prerequisite for filing a VAERS report. When in doubt, providers should report to VAERS. VAERS solicits reports for all events temporally related to vaccination, some of which may be coincidental and some of which may merely indicate a change in the frequency of expected events. Post-marketing surveillance relies on health professionals to report suspicious events, thus improving the quality of reported data and contributing significantly to safeguarding public health. Recommendations for healthcare professionals to report to VAERS recently have been incorporated into the Standards for Pediatric Immunization Practices, which are endorsed by multiple professional organizations. Despite the limitations of spontaneous reports, VAERS provides vital information of clinical importance. The identification of signals in adverse event surveillance may initiate further investigation of potential problems in vaccine safety or efficacy, and facilitate subsequent dissemination of safety-related information to the scientific community and the public. This process begins with voluntary submission of reports of possible vaccine-associated events to VAERS by the informed and conscientious health professional.
Similar articles
-
Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.MMWR Surveill Summ. 2003 Jan 24;52(1):1-24. MMWR Surveill Summ. 2003. PMID: 12825543
-
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.Pediatrics. 2001 May;107(5):E83. doi: 10.1542/peds.107.5.e83. Pediatrics. 2001. PMID: 11331733
-
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.Pediatr Infect Dis J. 2004 Apr;23(4):287-94. doi: 10.1097/00006454-200404000-00002. Pediatr Infect Dis J. 2004. PMID: 15071280 Review.
-
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).Vaccine. 2015 Aug 26;33(36):4398-405. doi: 10.1016/j.vaccine.2015.07.035. Epub 2015 Jul 22. Vaccine. 2015. PMID: 26209838 Free PMC article. Review.
-
Elective termination of pregnancy after vaccination reported to the Vaccine Adverse Event Reporting System (VAERS): 1990-2006.Vaccine. 2008 May 2;26(19):2428-32. doi: 10.1016/j.vaccine.2008.02.052. Epub 2008 Mar 17. Vaccine. 2008. PMID: 18406499 Review.
Cited by 16 articles
-
Effectiveness of a Census-Based Management Information System for Guiding Polio Eradication and Routine Immunization Activities: Evidence from the CORE Group Polio Project in Uttar Pradesh, India.Am J Trop Med Hyg. 2019 Oct;101(4_Suppl):33-44. doi: 10.4269/ajtmh.18-0935. Am J Trop Med Hyg. 2019. PMID: 31760973 Free PMC article.
-
Safety profile of the meningococcal conjugate vaccine (Menafrivac™) in clinical trials and vaccination campaigns: a review of published studies.Hum Vaccin Immunother. 2020 Jun 2;16(6):1245-1259. doi: 10.1080/21645515.2019.1652041. Epub 2019 Sep 5. Hum Vaccin Immunother. 2020. PMID: 31403358 Free PMC article.
-
Assessment of Quadrivalent Human Papillomavirus Vaccine Safety Using the Self-Controlled Tree-Temporal Scan Statistic Signal-Detection Method in the Sentinel System.Am J Epidemiol. 2018 Jun 1;187(6):1269-1276. doi: 10.1093/aje/kwy023. Am J Epidemiol. 2018. PMID: 29860470 Free PMC article.
-
Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States.Hum Vaccin Immunother. 2016 Jun 2;12(6):1406-17. doi: 10.1080/21645515.2016.1168952. Epub 2016 Mar 30. Hum Vaccin Immunother. 2016. PMID: 27029786 Free PMC article.
-
Vaccine Safety Resources for Nurses.Am J Nurs. 2015 Aug;115(8):55-8. doi: 10.1097/01.NAJ.0000470404.74424.ee. Am J Nurs. 2015. PMID: 26222474 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical